Victory Capital Management Inc Capricor Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.0 - $8.5 $685 - $5,822	-685 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$0.94 - $2.02 $57 - $123	61 Added 9.78%	685 $1,000
Q4 2019 Feb 04, 2020	BUY	$1.04 - $3.55 $176 - $603	170 Added 37.44%	624 $1,000
Q3 2019 Nov 12, 2019	BUY	$2.38 - $6.23 $1,080 - $2,828	454 New	454 $2,000

133

16M

1.73M

1.71M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $365M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.